<DOC>
	<DOCNO>NCT01993017</DOCNO>
	<brief_summary>The purpose study examine , randomize control trial , benefit cost American Heart Association 's ( AHA ) advisory depression screen treatment post-acute coronary syndrome patient .</brief_summary>
	<brief_title>Comparison Depression Identification After Acute Coronary Syndrome : Quality Life Cost Outcomes</brief_title>
	<detailed_description>Patients acute coronary syndrome ( ACS ) comorbid depression 2-fold high risk recurrent ACS mortality , bad quality life , high cost care nondepressed ACS patient . The strength observational finding prompt American Heart Association ( AHA ) advise routine depression screen ACS patient referral depression diagnosis treatment indicate occur . Unfortunately , randomize control trial ( RCT ) inform potentially expensive screening recommendation . Additionally , screen guidelines/advisories absence RCT evidence recently extensively criticize ( withdrawn ) . This pose serious dilemma clinician , health care system , health care policy leader . A RCT urgently need provide evidence different constituent cost benefit AHA depression screen treat algorithm . Two critical gap knowledge must fill determine public health would improve AHA strategy depression screen post-ACS patient : 1 ) Does strategy improve quality-adjusted life year patient recent ACS 2 ) Is cost provide depression screen type depression treatment within acceptable typical amount reimburse health care service ? Our specific aim determine quality-adjusted life year benefit health care cost follow AHA 's advisory depression screen referral diagnosis treatment post-ACS patient , depression find . To accomplish aim , randomize patient three different , geographically diverse health maintenance organization three different group : 1 ) AHA depression screen treat depression find algorithm ( intervention group ) : 2 ) receive depression screening ( strong control group ) : 3 ) screen primary care provider notify ( minimally enhance control group ) . Health-related quality life , depressive symptom , cost obtain patient , benefit cost three different depression screen strategy compare .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<criteria>Englishspeaking With document acute coronary syndrome ( ACS ) within past 26 month Over age 21 year Has access phone computer Medical Exclusions : Terminal illness ( life expectancy &lt; 1 year determine physician/medical record ) define , limited : NYHA class IV , ACC class D CHF require inotropes mechanical assist device critical aortic stenosis without plan correction Endstage COPD/emphysema Advanced cirrhosis encephalopathy , varix , severe ascites Severe rheumatologic disease require frequent hospitalization , multiple cytotoxic agent and/or disease modify drug Metastatic pancreatic , esophageal , colorectal stomach cancer Metastatic sarcoma , ovarian , melanoma renal cell cancer Metastatic breast cancer multiple recurrences despite treatment Advanced CNS malignancy Recurrent hematologic malignancy multiple recurrence despite treatment Persistent AIDS , untreated treated Psychiatric Exclusions : Dementia History bipolar disorder History psychosis History major depression History suicide attempt selfinflicted injurys Current alcohol substance abuse Currently receive depression treatment</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Acute Coronary Syndrome</keyword>
	<keyword>Depressive Symptoms</keyword>
</DOC>